Other languages Renalytix Plc Nasdaq

Equities

RNLX

US75973T1016

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
0.6358 ^USD	-9.11%		-23.40%	+63.03%

Apr. 18	Renalytix chief business officer to become president	AN
Apr. 18	Renalytix Names Chief Business Officer as President	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Renalytix chief business officer to become president	Apr. 18
Renalytix plc Announces Executive Changes, Effective from April 30, 2024	Apr. 18
Renalytix Issues New Shares for Convertible Bonds Repayment	Apr. 10
Renalytix announces financing of up to USD4 million	Apr. 08
Renalytix to Raise Up to $4 Million via Share Offering	Apr. 08
Horizonte subsidiary hit with debt injunction	Mar. 14
Renalytix plc's KidneyIntelX Included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease	Mar. 14
Renalytix Raises $12 Million via Equity Placing to Extend Cash Runway	Mar. 12
Renalytix shares sink on heavily discounted placing	Mar. 12
Renalytix Targets $10 Million Equity Raise to Extend Cash Runway	Mar. 12
Renalytix Kicks Off Formal Sale Process Following Approach from Unnamed Diagnostics Company	Mar. 04
Renalytix shares up as company commences formal sale process	Mar. 04
Renalytix Expands US Coverage for Kidney Disease Test	Feb. 29
Renalytix up as kidneyintelX.dkd authorised for US government contract	Feb. 29
Renalytix narrows annual loss but cash balance and revenue fall	Feb. 15
Renalytix Plc Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14
Wall Street Set to Open Modestly Higher as S&P Hovers Just Above 5,000	Feb. 09
Renalytix up after US CMS issues draft local coverage determination	Feb. 09
Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for Renalytix Plc's Kidneyintelx and Kidneyintelx.Dkd	Feb. 09
Renalytix plc Announces Update on Kidneyintelx.Dkd Local Coverage Determination Consideration	Jan. 17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Renalytix Plc Nasdaq

Equities

RNLX

US75973T1016

Other languages

Filters